Extracorporeal Membrane Oxygenation Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: ECMO Disposables and ECMO Machines

Global Extracorporeal Membrane Oxygenation Market Report to 2032

The global extracorporeal membrane oxygenation market was valued at $99 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 7.9%, reaching $169 million by 2032.

This report covers the global market for extracorporeal membrane oxygenation (ECMO), including ECMO disposable kits and ECMO machines used to provide advanced cardiac and respiratory support.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by the rising incidence of cardiovascular and severe respiratory diseases, increasing coronary heart disease prevalence, and broad physician familiarity with ECMO placement. However, alternatives such as VADs and heart-lung machines, along with competitive pricing pressure, are expected to limit stronger market value growth.

Market Overview

The global extracorporeal membrane oxygenation market includes devices used to provide temporary cardiac and respiratory support for critically ill patients. ECMO systems oxygenate blood outside the body and return it to the patient, supporting circulation and gas exchange when the heart or lungs are unable to function adequately.

The market includes ECMO machines and ECMO disposables. Machines represent the capital equipment used to run the system, while disposables include oxygenators, tubing kits, filters, and other single-use components needed during treatment.

Ongoing growth in ECMO utilization is supported by the rising global incidence of cardiovascular and severe respiratory diseases. Increasing rates of coronary heart disease, heart failure, and acute respiratory conditions have expanded the potential patient population requiring advanced life support.

This trend is expected to sustain moderate growth in ECMO procedures over the forecast period. However, the market is also becoming more competitive, with firms competing on price across several regions. This pricing pressure is expected to limit total market value growth despite rising utilization.

Market Drivers

Increasing Incidence of Coronary Heart Disease

The increasing incidence of coronary heart disease is a major driver of ECMO adoption. Coronary heart disease is strongly associated with age and remains one of the leading causes of death worldwide.

As the global geriatric population increases, the number of patients at risk for severe cardiovascular disease is expected to grow. According to the United Nations, the number of people aged 80 years or older is projected to reach 426 million by 2050, up from 143 million in 2019.

This demographic shift is expected to increase demand for advanced cardiac support technologies. ECMO machines and disposables are used in selected high-acuity cases where patients require temporary support, making cardiovascular disease prevalence an important long-term growth factor.

Severe Respiratory Disease Burden

Severe respiratory disease is another important driver of ECMO procedure growth. ECMO can be used for patients with acute respiratory conditions when conventional support is not sufficient.

As healthcare systems improve their ability to identify and treat severe respiratory failure, ECMO may be used more often in specialized critical care settings. This supports demand for both machines and recurring disposable kits.

The market is also supported by broader awareness of ECMO as an advanced life support option. Hospitals with established critical care and cardiac surgery programs may continue expanding ECMO capabilities as part of broader cardiopulmonary support services.

Ease of Use and Physician Familiarity

Ease of use and physician familiarity are key drivers in the ECMO market. Most cardiac surgeons are familiar with placing ECMO in a patient, and a growing number of cardiologists are entering the field.

Since many cardiologists and cardiac specialists understand how to use ECMO, there is a large and growing clinical base for ECMO products. This familiarity supports adoption and helps maintain procedural demand.

As more physicians gain experience with ECMO, access may expand across specialized hospitals and advanced care centers. This can support unit sales of disposables and encourage investment in ECMO machines over the forecast period.

Market Limiters

Alternatives

Alternatives remain an important limiter for the ECMO market. Ventricular assist devices are a popular and growing treatment alternative to ECMO in certain patient groups.

VADs can provide mechanical circulatory support and may be preferred in some cases depending on patient condition, duration of support required, and clinical goals. Their growth is expected to stifle ECMO market expansion over the forecast period.

Heart-lung machines are another alternative that may limit ECMO growth. Although ECMO has specific clinical applications, competing support technologies can reduce the number of cases where ECMO is selected as the preferred option.

Competitive Pressures

Competitive pressures are expected to limit market value growth. Firms across the global ECMO market compete on price, particularly in regions where multiple established companies and local suppliers are active.

Competition between companies has the potential to drive a steady decrease in ASPs for ECMO devices. This affects both machines and disposables, especially when hospitals compare product costs closely.

Even if procedure volumes rise, lower ASPs can reduce revenue growth. This pricing pressure is expected to continue over the forecast period and limit the total value of the ECMO market.

Capital Equipment Constraints

ECMO machines require capital investment, which can limit adoption in hospitals with constrained budgets. While disposables generate recurring revenue, machine purchases depend on facility resources, procedure volume expectations, and critical care infrastructure.

Smaller hospitals or facilities with limited ECMO utilization may be cautious about investing in new systems. Even when clinical need exists, adoption may be concentrated in advanced centers with trained teams and established patient pathways.

This creates a barrier to broader market expansion. Manufacturers must balance machine placement, disposable utilization, training, and service support to build sustainable ECMO programs.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers extracorporeal membrane oxygenation devices, including ECMO machines and ECMO disposables used for advanced cardiac and respiratory support.

Markets Covered and Segmentation

Extracorporeal Membrane Oxygenation Market

• Device type: ECMO disposables and ECMO machines.

ECMO disposables include single-use components required during ECMO procedures. These may include oxygenators, tubing kits, filters, and other disposable products used to support blood oxygenation and circulation outside the body.

ECMO machines include the capital systems used to operate ECMO support. These systems control blood flow, support oxygenation, and help manage temporary cardiopulmonary support in critically ill patients.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how disposable utilization, machine adoption, critical care capacity, disease burden, physician familiarity, and competitive pricing pressure are shaping the global ECMO market.

Competitive Analysis

Medtronic was the leading company in the global ECMO market in 2025. The company's capital equipment product line includes the Affinity(R) and Minimax(R) oxygenation systems.

Medtronic also offers disposable products, giving it room to expand its market presence over the coming years. Its participation across both capital and disposable categories supports its competitive position and allows the company to serve hospitals across different ECMO purchasing needs.

Getinge was the second-leading company in the global ECMO market in 2025. The company offers both disposables and machines and has a global presence.

As the number of patients able to access ECMO rises, Getinge is expected to gain some share. Its broad cardiopulmonary support portfolio and established hospital relationships support continued participation in ECMO growth.

Terumo was the third-leading competitor in the global ECMO market in 2025. The company offers its CAPIOX(R) line of oxygenators, along with a comprehensive portfolio of ECMO-related disposable products, including custom tubing kits and filters.

Terumo's broad consumables offering supports its competitive positioning across multiple regions. However, increasing market fragmentation and pricing pressure will continue to shape competitive dynamics.

Technology and Practice Trends

Disposable Kit Utilization

Disposable kits are central to ECMO market value because each procedure requires single-use components. As ECMO utilization rises, demand for oxygenators, tubing kits, filters, and related disposables is expected to increase.

This supports recurring revenue even when machine purchases are more limited.

Growth in Advanced Life Support

ECMO is becoming a more important part of advanced life support in specialized cardiac and critical care settings. Rising rates of severe cardiac and respiratory disease are supporting broader use.

Hospitals with established ECMO programs are expected to remain key adoption centers.

Physician Familiarity

Most cardiac surgeons are familiar with ECMO placement, and more cardiologists are entering the field. This growing base of trained users supports broader adoption.

Training and comfort with ECMO workflows will remain important to procedure growth.

Competitive Pricing

Competitive pricing is an important market trend. As more companies compete globally, ASP pressure is expected to continue.

This may limit market value growth even when unit demand increases.

ECMO Versus VADs

VADs remain an important alternative to ECMO in certain patients. Device selection depends on the type of support required, expected duration of use, and patient condition.

This competition will continue to influence ECMO adoption.

Machine Placement and Program Development

ECMO machine adoption depends on hospital infrastructure, clinical team readiness, and expected utilization. Facilities with higher critical care volumes are more likely to support sustainable ECMO programs.

Machine placement strategies must be aligned with disposable usage, training, and long-term service support.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global extracorporeal membrane oxygenation market today, and how much is it expected to grow through 2032?
• How are ECMO disposables and ECMO machines performing across the forecast period?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• What role does ECMO play in advanced cardiac and respiratory support?
• How is the rising incidence of coronary heart disease affecting ECMO adoption?
• How is the growing elderly population influencing demand for advanced life support technologies?
• Why does physician familiarity support ECMO market growth?
• How are VADs and heart-lung machines affecting ECMO adoption?
• What impact does competitive pricing pressure have on market value?
• Which companies lead the global ECMO market?

The Global Extracorporeal Membrane Oxygenation Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand cardiopulmonary support trends, and support commercial planning in the global ECMO market.